126 related articles for article (PubMed ID: 37579857)
1. Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines.
Xu Z; Wang H; Meng Q; Ding Y; Zhu M; Zhou H; Zhang N; Shi L
Biochem Pharmacol; 2023 Sep; 215():115746. PubMed ID: 37579857
[TBL] [Abstract][Full Text] [Related]
2. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.
Zhou D; Xu Z; Huang Y; Wang H; Zhu X; Zhang W; Song W; Gao T; Liu T; Wang M; Shi L; Zhang N; Xiong B
Eur J Med Chem; 2023 Jun; 254():115369. PubMed ID: 37075624
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.
Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A
J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159
[TBL] [Abstract][Full Text] [Related]
5. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
[TBL] [Abstract][Full Text] [Related]
7. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.
Ruiz EJ; Pinto-Fernandez A; Turnbull AP; Lan L; Charlton TM; Scott HC; Damianou A; Vere G; Riising EM; Da Costa C; Krajewski WW; Guerin D; Kearns JD; Ioannidis S; Katz M; McKinnon C; O'Connell J; Moncaut N; Rosewell I; Nye E; Jones N; Heride C; Gersch M; Wu M; Dinsmore CJ; Hammonds TR; Kim S; Komander D; Urbe S; Clague MJ; Kessler BM; Behrens A
Elife; 2021 Oct; 10():. PubMed ID: 34636321
[TBL] [Abstract][Full Text] [Related]
8. Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon.
Santicioli P; Zagorodnyuk V; Renzetti AR; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):420-7. PubMed ID: 10498293
[TBL] [Abstract][Full Text] [Related]
9. USP28 promotes aerobic glycolysis of colorectal cancer by increasing stability of FOXC1.
Liu Z; Chen M; Xu X; Zhang L; Pan Y; Chen D
Acta Biochim Pol; 2021 Jun; 68(4):633-639. PubMed ID: 34106567
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Toxicity Due to Otilonium Bromide Overdose: A Case Report.
Zaki SA; Helal ME; Rashid A
J Emerg Med; 2022 Mar; 62(3):e47-e50. PubMed ID: 35031171
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression.
Wang Z; Song Q; Xue J; Zhao Y; Qin S
Exp Biol Med (Maywood); 2016 Feb; 241(3):255-64. PubMed ID: 26209720
[TBL] [Abstract][Full Text] [Related]
12. Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier.
Catalioto RM; Triolo A; Giuliani S; Altamura M; Evangelista S; Maggi CA
J Pharm Sci; 2008 Sep; 97(9):4087-100. PubMed ID: 18200532
[TBL] [Abstract][Full Text] [Related]
13. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
Glende M; Morselli-Labate AM; Battaglia G; Evangelista S
Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of otilonium bromide against Vibrio vulnificus.
Gong Y; Kim YR
Res Microbiol; 2023; 174(1-2):103992. PubMed ID: 36122890
[TBL] [Abstract][Full Text] [Related]
15. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
[TBL] [Abstract][Full Text] [Related]
16. USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.
Prieto-Garcia C; Hartmann O; Reissland M; Braun F; Bozkurt S; Pahor N; Fuss C; Schirbel A; Schülein-Völk C; Buchberger A; Calzado Canale MA; Rosenfeldt M; Dikic I; Münch C; Diefenbacher ME
Mol Oncol; 2022 Sep; 16(17):3082-3106. PubMed ID: 35364627
[TBL] [Abstract][Full Text] [Related]
17. Computational approach to target USP28 for regulating Myc.
Chakravorty D; Ghosh A; Saha S
Comput Biol Chem; 2020 Apr; 85():107208. PubMed ID: 32028107
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the bi-specificity of USP25 and USP28 inhibitors.
Patzke JV; Sauer F; Nair RK; Endres E; Proschak E; Hernandez-Olmos V; Sotriffer C; Kisker C
EMBO Rep; 2024 May; ():. PubMed ID: 38816515
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc/hypoxia-inducible factor-1 alpha pathway.
Weili Z; Zhikun L; Jianmin W; Qingbao T
J Cell Biochem; 2019 Jan; 120(1):201-212. PubMed ID: 30206969
[TBL] [Abstract][Full Text] [Related]
20. Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome.
Czimmer J; Süto G; Király A; Mózsik G
J Physiol Paris; 2001; 95(1-6):153-6. PubMed ID: 11595430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
